• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail

S6(R1) Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals

S6(R1) Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals

 

 

Note: In June 2011, the ICH incorporated the S6 Addendum with S6 and retitled the combined document S6(R1). The contents of S6 and the S6 Addendum reflect the contents of S6(R1).

 

Back to: International Conference on Harmonisation - Safety